6.700
+0,00%
2026-10-16
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -33.5% | +38.5% | 2 / 3 | -43.1% | +6.55 pp | +2.68 pp | +8.8% | 0.00 | 6.82 | 21,3 | −43,1% | 3,9 | −33,5% | 6.82 | 6.94 | −1,7% |
| Pts | 0 | 8 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.700 (close price on 2026-10-16)EPS (TTM): 982,1
Financial charts
1.Revenue & growth
VND bn21,3Q2/26
1.Revenue & growth
VND bn21,3Q2/26
2.Profit & growth
VND bn3,76Q2/26
3.Profit mix (Penman)
VND bn20,2Q2/26
4.Margins & cost structure
%29.3%Q2/26
5.Returns & cash cycle
% · days14.4%Q2/26
6.Earnings quality & cash
VND bn15,6Q2/26
7.Asset structure
VND bn188Q2/26
8.Funding & debt health
VND bn · times188Q2/26
9.Revenue backlog
VND bn0,17Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %228Q2/26
Adjusted EPS growth, latest quarter
-36.1%
Average adjusted EPS growth, 3 quarters
37.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26